west-coast-vc
(2)
Julie Grant
Julie Grant is a General Partner at Canaan, a $5B technology and healthcare venture capital firm, where she leads biopharma investments and company formation on the West Coast. She co-founded and served as founding CEO of Day One Biopharmaceuticals, a purpose-built pediatric oncology company that grew to a $1.5B+ valuation and was later acquired by Servier. A Yale-educated molecular biophysicist who went on to Stanford MBA and Cambridge MPhil, Grant brings rare operational depth to venture - having sat in the CEO chair before returning to investing. In 2023, President Biden appointed her to the National Cancer Advisory Board. She is the fourth woman to become a General Partner at Canaan.
Dave Strohm
Dave Strohm is one of Silicon Valley's longest-tenured venture investors, joining Greylock Partners in 1980 and opening the firm's West Coast office in 1983. Over four decades, he has been an early or founding investor in more than 30 companies - more than a dozen of which went public - spanning enterprise software, cybersecurity, infrastructure, and e-commerce. His most storied bets include DoubleClick (sold to Google), SuccessFactors (sold to SAP), Internet Security Systems (sold to IBM), OpenDNS (sold to Cisco), Mentor Graphics (sold to Siemens), and Ascend Communications. He served as Chairman of SuccessFactors for nearly a decade and as Lead Independent Director of EMC Corporation for twelve years. Today he serves as Venture Partner at Greylock and Special Advisor at 83North, with active board positions at Oportun, ASAPP, MATRIXX Software, RichRelevance, and Bounty Jobs.